GPT Healthcare Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹18.5(9.95%)
Premium (ELP)
The public market debut of GPT Healthcare Limited's was completed on Feb 29, 2024 with its listing on the NSE, BSE exchange. The IPO process raised 2,82,33,323 Shares in total capital, consisting of 21,50,537 Shares in new equity and ₹485.00 Cr in existing share sales through the OFS route.
The offering featured a price range of ₹177 to ₹186 and minimum application size of 80 shares. Investor response during the subscription period from Feb 22, 2024 to Feb 26, 2024 influenced the final allotment ratios across investor categories.
Final allotment was announced on Feb 27, 2024, distributing shares to successful subscribers. The listing established a continuous market for the company's shares, enabling liquidity, valuation transparency, and broader investor participation.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty hospitals under the ILS Hospitals brand, providing integrated secondary and tertiary healthcare services in Eastern India. Headquartered in Kolkata, West Bengal, the company offers a comprehensive range of medical services across 35+ specialties and super-specialties, including nephrology, cardiology, neurology, gastroenterology, orthopaedics, laparoscopic surgery, and paediatrics. GPT Healthcare runs four hospitals with a total capacity of 561 beds, strategically located in Salt Lake (Kolkata), Dum Dum (Kolkata), Howrah, and Agartala. As of June 30, 2023, the company employed 1,855 professionals, including 85 full-time consultants and 465 visiting consultants, ensuring high-quality patient care and medical expertise.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Strategic Market Position: Its presence in underserved and high-density markets provides a competitive edge, driving both patient volumes and revenue growth.
- Optimized Hospital Infrastructure: The company’s focus on ‘right-sized’ hospitals ensures efficient capital utilization, maximizing returns while maintaining high-quality healthcare services.
- Diversified Specialty and Location Mix: A broad range of specialties and a strategic geographic footprint reduce dependence on any single market segment, making the business more resilient to industry shifts.
- Talent Magnetism: The ability to attract and retain top medical talent reinforces the company’s reputation for quality care, further strengthening patient trust and operational performance.
- Regional Economic and Political Conditions: Heavy reliance on hospitals in West Bengal makes the provider susceptible to local economic downturns, policy changes, and political instability, potentially disrupting operations.
- Specialty Dependency: Over-reliance on specific medical specialties may lead to revenue volatility if demand shifts or new medical trends emerge, necessitating diversification in service offerings.
- Dependency on Healthcare Professionals: With a strong reliance on consultancy-based doctors, recruitment and retention challenges could disrupt service continuity and affect patient satisfaction.
- Nurse Availability and Quality of Care: A shortage of trained nurses could impact the quality of care, increase regulatory scrutiny, and strain operational efficiency.
- Regulatory and Compliance Risks: Stringent healthcare regulations require continuous adherence, and any lapses could result in financial penalties, legal challenges, and reputational damage.
- GPT Sons Private Limited
- Dwarika Prasad Tantia
- Dr. Om Tantia
- Shree Gopal Tantia
GPT Healthcare Limited
Link Intime India Private Limited